Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation

Marrow Transplantation ◽

Thalassemia Major ◽

Allogeneic Blood ◽

Beta Thalassemia ◽

Short Term ◽

Host Disease ◽

Graft Versus Host ◽

Cyclosporin A and mini short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation

10.1016/j.bbmt.2005.11.157 ◽

2006 ◽

Vol 12 (2) ◽

pp. 50

Author(s):

M. Iravani ◽

A. Mousavi ◽

S. Gholibeikian ◽

B. Bahar ◽

S. Samiee ◽

...

Keyword(s):

Cyclosporin A ◽

Marrow Transplantation ◽

Thalassemia Major ◽

Allogeneic Blood ◽

Beta Thalassemia ◽

Short Term ◽

Host Disease ◽

Graft Versus Host ◽

Associations Among Inflammation, Perceived Stress, and Lifestyle Behaviors of Individuals with Chronic Graft-Versus-Host Disease (cGVHD) Following Allogeneic Blood and Marrow Transplantation

10.1016/j.bbmt.2015.11.568 ◽

2016 ◽

Vol 22 (3) ◽

pp. S187

Author(s):

Debra Lynch Kelly ◽

Debra E. Lyon ◽

Cynthia Garvan ◽

John R. Wingard

Keyword(s):

Perceived Stress ◽

Marrow Transplantation ◽

Allogeneic Blood ◽

Lifestyle Behaviors ◽

Host Disease ◽

Graft Versus Host ◽

Expression of CD62L on Donor CD4+ T Cells in Allografts: Correlation with Graft-Versus-Host Disease after Unmanipulated Allogeneic Blood and Marrow Transplantation

Journal of Clinical Immunology ◽

10.1007/s10875-009-9293-9 ◽

2009 ◽

Vol 29 (5) ◽

pp. 696-704 ◽

Cited By ~ 16

Author(s):

Ying-Jun Chang ◽

Xiang-Yu Zhao ◽

Ming-Rui Huo ◽

Xiao-Jun Huang

Keyword(s):

T Cells ◽

Cd4 T Cells ◽

Marrow Transplantation ◽

Allogeneic Blood ◽

Host Disease ◽

Graft Versus Host ◽

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults

Clinical Hematology International ◽

10.2991/chi.d.200115.001 ◽

2020 ◽

Author(s):

Cosmin Tegla ◽

Jun Choi ◽

Maher Abdul-Hay ◽

Frank Cirrone ◽

Kelli Cole ◽

...

Keyword(s):

Disease Prevention ◽

Marrow Transplantation ◽

Allogeneic Blood ◽

Current Status ◽

Future Directions ◽

Host Disease ◽

Graft Versus Host ◽

Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2021.01.005 ◽

2021 ◽

Author(s):

Saurabh Chhabra ◽

Alexis Visotcky ◽

Marcelo C. Pasquini ◽

Fenlu Zhu ◽

Xiaoying Tang ◽

...

Keyword(s):

Cell Transplantation ◽

Marrow Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Host Disease ◽

Graft Versus Host ◽

Post-Transplantation Cyclophosphamide (PTCy) Based Graft Versus Host Disease (GVHD) Prophylaxis in Patients Undergoing Allogeneic Blood or Marrow Transplantation (BMT) for Myelofibrosis (MF)

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00204-9 ◽

2021 ◽

Vol 27 (3) ◽

pp. S164-S165

Author(s):

Tania Jain ◽

Hua-Ling Tsai ◽

Amy E. DeZern ◽

Hany Elmariah ◽

Ravi Varadhan ◽

...

Keyword(s):

Marrow Transplantation ◽

Allogeneic Blood ◽

Post Transplantation ◽

Host Disease ◽

Graft Versus Host ◽

Gvhd Prophylaxis

Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma

10.1016/j.bbmt.2017.07.003 ◽

2017 ◽

Vol 23 (11) ◽

pp. 1903-1909 ◽

Cited By ~ 9

Author(s):

Nilanjan Ghosh ◽

Xiaobu Ye ◽

Hua-Ling Tsai ◽

Javier Bolaños-Meade ◽

Ephraim J. Fuchs ◽

...

Keyword(s):

Multiple Myeloma ◽

Marrow Transplantation ◽

Allogeneic Blood ◽

Post Transplantation ◽

Host Disease ◽

Graft Versus Host

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

Leukemia ◽

10.1038/sj.leu.2403343 ◽

2004 ◽

Vol 18 (5) ◽

pp. 1013-1019 ◽

Cited By ~ 37

Author(s):

Y Kanda ◽

K Izutsu ◽

H Hirai ◽

H Sakamaki ◽

T Iseki ◽

...

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Cyclosporin A ◽

Marrow Transplantation ◽

Host Disease ◽

Graft Versus Host ◽

Sibling Donor ◽

Gvhd Prophylaxis

Corrigendum to ‘Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults’ [Biology of Blood and Marrow Transplantation 26/2 (2020) 367-372]

10.1016/j.bbmt.2020.02.008 ◽

2020 ◽

Author(s):

Norimichi Hattori ◽

Bungo Saito ◽

Tomoharu Matsui ◽

Ayaka Nakata ◽

Yohei Sasaki ◽

...

Keyword(s):

Comparative Study ◽

Umbilical Cord Blood ◽

Marrow Transplantation ◽

Cord Blood Transplantation ◽

Umbilical Cord Blood Transplantation ◽

Short Term ◽

Graft Versus Host ◽

Blood And Marrow Transplantation ◽

Blood Transplantation

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

10.1016/j.bbmt.2012.04.005 ◽

2012 ◽

Vol 18 (8) ◽

pp. 1150-1163 ◽

Cited By ~ 304

Author(s):

Paul J. Martin ◽

J. Douglas Rizzo ◽

John R. Wingard ◽

Karen Ballen ◽

Peter T. Curtin ◽

...

Keyword(s):

Marrow Transplantation ◽

Systemic Treatment ◽

Second Line ◽

Host Disease ◽

Graft Versus Host ◽

Blood And Marrow Transplantation ◽

American Society ◽

Acute Graft